RenovaCare, Inc. Appoints Roger Esteban-Vives as Vice President of Research and Product Development
June 06, 2019 at 01:30 pm
Share
RenovaCare, Inc. announced the appointment of Dr. Roger Esteban-Vives as Vice President of Research and Product Development. The appointment of Dr. Esteban-Vives follows a November 2018 equity financing of $15.5 million by Kalen Capital Corporation, wholly owned by Mr. Harmel S. Rayat, the Company’s Chairman. Considered a leading expert in the isolation of specific stem cells that are ideal for spraying onto burns and wounds, Dr. Esteban-Vives has served as Director of Cell Sciences at RenovaCare since late 2016 until his appointment as Vice President of Research and Product Development on June 1st, 2019.
RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patientâs own cells) cellular therapies that can be used for medical and aesthetic applications. The Companyâs CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patientâs own skin or other tissues. The resulting stem cell suspension is administered topically from the Companyâs novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.
RENOVACARE, INC. 
